Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
Clinical trial NCT03303092 · COMPLETED
Trial details
- NCT number
- NCT03303092
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2019-11-22
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.